‘The bane of my life’: Authority approvals under scrutiny A recent audit report has shed light on how one of the great admin burdens for general practice became even more onerous. What more can be done?
Prescriber reminder over oral contraceptive PBS changes Yaz and Yasmin are now available on the PBS – but existing patients will need a new prescription to access the lower price.
What to expect from incoming menopause health checks A new Medicare rebate is on the way, but what is a menopause health assessment and how will it improve the care women receive?
What does the $573m women’s health package mean for GPs? Labor’s plan, matched by the Coalition, includes new PBS listings for contraceptive pills and MHT, new rebates, funded training, and bolstered Medicare payments for IUD insertions.
‘Life-changing’ eczema drug to stay on PBS Dupixent was at high risk of coming off the PBS as soon as this month due to high demand, but negotiations have secured its continued listing.
Endometriosis drug Visanne added to PBS Doctors have described dienogest as ‘miraculous’, with its listing expected to positively impact up to 500,000 patients.
‘Unprecedented’ demand on PBAC forces extra meeting Its capacity has been exceeded by a ‘huge pipeline of new medicines’, after companies put forward a record number of submissions.
Action taken amid continuing PrEP shortage As supply of the HIV prevention medication continues to be disrupted, the Federal Government has listed a US brand on the PBS to shore up access.
Admin burden top reason GPs plan to leave practice: RACGP In a ‘wakeup call’ for governments, the new Health of the Nation report found 70% of GPs are concerned about their admin workload.
PBS additions for cancer and epilepsy Tens of thousands of patients each year are set to benefit from several first-time additions, including Zyamis and Tecentriq SC.